Literature DB >> 25027393

Significance of estrogen receptor subtypes in breast tumorigenesis and progression.

Weiliang Sun1, Chijiang Gu, Minming Xia, Guoping Zhong, Haojun Song, Junming Guo.   

Abstract

The aim of the study was to investigate the effects of estrogen receptor (ER) subtypes (ERα and ERβ) on breast cancer development and progression. The expression level of ERα and ERβ in breast cancer tissues and paired normal breast tissues were detected by Western blot analysis and immunohistochemistry (IHC) staining. The features of ERα and ERβ status in cancer tissues or normal breast tissues and the correlations between clinicopathological characteristics and prognosis were analyzed. The expression levels of ERα and ERβ in breast cancer tissues are significantly lower than those in the paired normal tissues. The expression of ERβ is decreased more than that of ERα. ERα expression levels in cancer tissues are associated with tumor diameter, tumor-node-metastasis (TNM) stage, and progesterone receptor (PR) status. However, ERβ expression levels in cancer tissues are not correlated with clinicopathological factors of patients with breast cancer. In conclusion, ER subtypes might play different roles in the development of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027393     DOI: 10.1007/s13277-014-2152-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

Review 1.  Nuclear receptor-mediated transactivation through interaction with Sp proteins.

Authors:  Stephen Safe; Kyounghyun Kim
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

2.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

3.  Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.

Authors:  Edmund C Chang; Jonna Frasor; Barry Komm; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2006-06-29       Impact factor: 4.736

Review 4.  Estrogen receptor: current understanding of its activation and modulation.

Authors:  C K Osborne; R Schiff; S A Fuqua; J Shou
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

5.  Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.

Authors:  Loredana Mauro; Stefania Catalano; Gianluca Bossi; Michele Pellegrino; Ines Barone; Sara Morales; Cinzia Giordano; Viviana Bartella; Ivan Casaburi; Sebastiano Andò
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

6.  Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.

Authors:  Kelly J Higgins; Shengxi Liu; Maen Abdelrahim; Kathryn Vanderlaag; Xinyi Liu; Weston Porter; Richard Metz; Stephen Safe
Journal:  Mol Endocrinol       Date:  2007-11-15

7.  Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.

Authors:  Luisa Salvatori; Pierlorenzo Pallante; Linda Ravenna; Patrizia Chinzari; Luigi Frati; Matteo A Russo; Elisa Petrangeli
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

8.  Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor alpha through its interaction with Sp1.

Authors:  M L Panno; L Mauro; S Marsico; D Bellizzi; P Rizza; C Morelli; M Salerno; F Giordano; S Andò
Journal:  J Mol Endocrinol       Date:  2006-02       Impact factor: 5.098

Review 9.  Rapid actions of steroid receptors in cellular signaling pathways.

Authors:  Andrew C B Cato; Andrea Nestl; Sigrun Mink
Journal:  Sci STKE       Date:  2002-06-25

10.  Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer.

Authors:  L C Murphy; E Leygue; Y Niu; L Snell; S-M Ho; P H Watson
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

View more
  2 in total

Review 1.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.

Authors:  Flavia Zita Francies; Rodney Hull; Richard Khanyile; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 5.942

2.  17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells.

Authors:  Anissa Belkaid; Sabrina R Duguay; Rodney J Ouellette; Marc E Surette
Journal:  BMC Cancer       Date:  2015-05-29       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.